Prediabetes and diabetes screening outreach

Primary care, family medicine, internal medicine and community health practices see the adults who qualify for prediabetes and type 2 diabetes screening, and the CDC says more than 2 in 5 adults in the United States have prediabetes and 8 in 10 of them do not know they have it. That makes screening a real service to tell patients about. It also makes the message easy to get wrong: a flyer that offers free blood sugar checks to Medicare patients at a store, a page that promises to reverse diabetes, or a reminder that reads like an ad. This guide covers what the federal sources say about who should be screened, how the Medicare benefit works, what to do after a prediabetes result, and how to word pages and reminders so they stay accurate.

Related topics have their own guides and are not repeated here. Lifestyle programs are covered in our guides to diabetes prevention program marketing and diabetes education program marketing, Medicare wellness visits in our guide to annual wellness visit outreach, and screening at community events in our guide to health fair screening event marketing. Weight counseling is in our guide to Medicare obesity counseling outreach, and eye exams for patients who already have diabetes are in our guide to diabetic eye exam outreach. People with diabetes are also invited to kidney testing; see kidney disease screening outreach.

This is general information, not legal, billing or medical advice. Sources cited were checked on October 30, 2026: the USPSTF recommendation Screening for Prediabetes and Type 2 Diabetes (final statement dated August 24, 2021) and the USPSTF list of recommendations in progress, 42 CFR 410.18 and the Medicare.gov page on diabetes screenings, 42 CFR 410.79 on the Medicare Diabetes Prevention Program, the CDC pages Prediabetes: Your Chance to Prevent Type 2 Diabetes and Preventing Type 2 Diabetes with the Lifestyle Change Program, 45 CFR 147.130, 42 CFR 493.3 and 493.35, 42 U.S.C. 1320a-7a, 47 CFR 64.1200, 16 CFR 255.2 and 15 U.S.C. 45. Coverage and payment rules change, Medicaid rules differ by state and plan coverage differs by plan; check yours with your billing team and a health care attorney.

What the USPSTF recommends

The U.S. Preventive Services Task Force final recommendation on screening for prediabetes and type 2 diabetes is dated August 24, 2021. It gives a B grade to screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity, and says clinicians should offer or refer patients with prediabetes to effective preventive interventions. The statement applies to nonpregnant adults seen in primary care with no symptoms of diabetes, and defines overweight and obesity as a BMI of 25 or more and 30 or more.

The Task Force also tells clinicians to consider screening at an earlier age in people from groups with a higher prevalence of diabetes, or with a family history of diabetes, a history of gestational diabetes or a history of polycystic ovary syndrome, and says a BMI of 23 or more may be an appropriate cut point for Asian American adults. It lists fasting plasma glucose, HbA1c and the oral glucose tolerance test as screening tests, and says screening every 3 years may be a reasonable approach for adults with normal blood glucose levels. On the date we checked, the USPSTF list of recommendations in progress did not include this topic.

Say the care team can check whether a patient is due for a blood sugar test, based on age, weight and history.
Do not say every adult needs a yearly blood sugar test. The Task Force wording is about adults 35 to 70 with overweight or obesity, with earlier screening considered for some patients, and a 3-year interval for normal results.
Leave the choice of test and the timing to the clinician. Marketing copy should not pick between HbA1c and a fasting test.

The Medicare diabetes screening benefit

Medicare Part B coverage is set out in 42 CFR 410.18. Part B covers diabetes screening tests after a referral from a physician or qualified nonphysician practitioner to an individual at risk for diabetes. Covered tests include a fasting blood glucose test, post-glucose challenge tests such as an oral glucose tolerance test, and the hemoglobin A1C test. Medicare covers two tests within the 12-month period following the date of the person’s last diabetes screening test.

The regulation lists who is eligible. A person qualifies with hypertension, dyslipidemia, obesity (a BMI of 30 or more), or a prior finding of impaired fasting glucose or glucose intolerance. A person also qualifies with any two of these: overweight (a BMI over 25 and under 30), a family history of diabetes, age 65 or older, or a history of gestational diabetes or delivery of a baby weighing more than 9 pounds. The Medicare.gov page says the patient pays nothing if the provider accepts assignment.

Use: “Medicare Part B covers diabetes screening tests for people with certain risk factors. Ask us whether you qualify.”
Avoid: “Free diabetes test for everyone on Medicare” or “two free tests a year.” Coverage depends on risk factors and a referral, and the zero cost applies when the provider accepts assignment.
Have the billing lead confirm codes, diagnosis requirements and frequency before any page mentions Medicare.

Coverage outside Medicare

Under 45 CFR 147.130, non-grandfathered group health plans and health insurance issuers must cover, without cost-sharing, items and services that have in effect an A or B rating in the current USPSTF recommendations. The regulation has exceptions and timing rules, and plan details differ. Medicaid coverage is set by each state. A page can say diabetes screening is a recommended preventive service for adults who meet the criteria. It should not promise that a patient will pay nothing.

Use: “Screening is a preventive service the USPSTF recommends for adults who meet its criteria. Our front desk can check what your plan covers.”
Avoid: “No cost to you,” “covered by every insurance” or “free with any plan.”

After a prediabetes result: referral

The USPSTF recommendation has two halves: screen, and offer or refer patients with prediabetes to effective preventive interventions. The CDC describes the National Diabetes Prevention Program lifestyle change program as a yearlong program led by a trained Lifestyle Coach, delivered both in person and online, and says lifestyle changes can cut the risk of type 2 diabetes in half. That is a statement about research results across groups, not a promise for one patient.

For people with Medicare, 42 CFR 410.79 sets the eligibility rules for the Medicare Diabetes Prevention Program. A beneficiary must be enrolled in Part B, have a BMI of at least 25, or at least 23 if self-identified as Asian, have a qualifying HbA1c, fasting plasma glucose or oral glucose tolerance test result within the 12 months before the first session, have no previous diagnosis of diabetes other than gestational diabetes, not have end-stage renal disease, and not have received the set of MDPP services before. The program is furnished by enrolled MDPP suppliers, not by every practice.

Keep a referral list of CDC-recognized lifestyle programs and enrolled MDPP suppliers that serve your patients, in person and online.
Say what the practice does after a result: the clinician explains it and, for prediabetes, offers a referral.
Do not describe a referral program as part of the practice unless it is. Our guide to diabetes prevention program marketing covers practices that run one.
Patients who already have diabetes need care and education, not a prevention program. Our guide to diabetes education program marketing covers that side.

Other guidelines patients may see

The USPSTF statement summarizes the American Diabetes Association recommendation of that time, which called for screening all adults 45 years or older regardless of risk factors, and screening adults with overweight or obesity (a BMI of 25 or more, or 23 or more in Asian American persons) with one or more risk factors, regardless of age. The ADA updates its Standards of Care each year, so a page that cites the ADA should quote the current edition and give its year. The CDC patient page tells people to talk to their doctor about a blood sugar test if they have risk factors such as being overweight, being 45 years or older, or being physically active less than 3 times a week.

Patients may arrive with different numbers from different sources. The page does not need to settle that. It can say that the clinician decides who is due and when, based on the patient’s history and current guidance.

Pages that inform patients

Patients search for practical questions: what the test is, whether they need to fast, whether Medicare covers it, and when to repeat it. A short page that answers those questions in plain words, with a clinician’s review and links to the sources, serves them better than a banner offer.

Explain what screening is: a blood test that checks blood sugar, ordered by the clinician.
Say who the USPSTF recommendation covers and link it, with its date.
Explain fasting instructions only as the clinician writes them, since they depend on the test ordered.
Say what happens after a result: the clinician explains it, and the practice helps with a lifestyle program referral when prediabetes is found.
Offer the CDC’s short online risk questions as a starting point, and say the result is not a diagnosis.
Keep condition pages free of ad tracking pixels unless your attorney has reviewed the setup. Our guide to tracking pixels on practice websites covers tracking on health pages.

Screening at events

Blood sugar checks at a health fair, church or workplace bring two sets of rules. A glucose test is a laboratory test: under 42 CFR 493.3, a laboratory needs a CLIA certificate that fits the tests it performs, such as a certificate of waiver, unless it is exempt, and 42 CFR 493.35(b)(1) says health screening fairs and other temporary testing sites may be covered under the certificate of the designated primary site or home base. A free test can also be something of value: 42 U.S.C. 1320a-7a(a)(5) provides civil monetary penalties for offering remuneration to a Medicare or Medicaid beneficiary that the offeror knows or should know is likely to influence the beneficiary to choose a particular provider. Our guide to health fair screening event marketing covers both in detail.

Confirm the test is covered by the office’s CLIA certificate before the event is announced.
Plan what happens to an abnormal result on the spot, including who tells the person and how follow-up is arranged.
Do not tie a free check to booking a visit with the practice, and have a health care attorney review any free offer aimed at Medicare or Medicaid patients.

Claims to leave out

“Reverse diabetes,” “cure prediabetes” or “diabetes-free in 12 weeks.” No federal source cited here supports a promise like that for one patient.
“Catch diabetes before it starts” as a promise. The USPSTF found a moderate net benefit for screening and preventive interventions, which is not a promise for one person.
“Free diabetes test for all seniors” or any free offer built around Medicare.
Named drugs, devices or supplements in screening ads. Treatment choices belong with the clinician, not in marketing copy.
Fear wording such as “you could already have diabetes and not know it” aimed at one patient. Use the CDC figures as group statistics, with the source.
A patient’s story about weight or blood sugar used as an ad. Under 16 CFR 255.2(b), an ad that presents one consumer’s result is likely to be read as what others will generally achieve, unless that is substantiated or what people can generally expect is clearly disclosed, and claims must be truthful and substantiated under 15 U.S.C. 45.

Reminders for screening

Screening reminders work best inside the visit the patient is already due for, such as a physical or a Medicare wellness visit. Under 47 CFR 64.1200(a)(9)(iv), calls and texts to wireless numbers made by or on behalf of healthcare providers are exempt from prior express consent only when all of its conditions are met. They go only to the wireless number the patient provided, state the provider’s name and contact details, and are strictly limited to listed purposes, which include appointment and exam confirmations and reminders, wellness checkups and lab results. They contain no telemarketing, solicitation or advertising and no billing or other financial content, comply with HIPAA privacy rules, stay concise (generally 160 characters or fewer for a text), are limited to one message a day and three a week, and offer an easy opt out. Our guide to text message appointment reminders covers the wider setup.

Use: “[Practice name]: you are due for a checkup. Call [phone] or book in the portal. Reply STOP to opt out.”
Avoid: “Free blood sugar test this week!” or any promotional wording in a reminder sent under the healthcare exemption.
Do not put a diagnosis, a test value or the word prediabetes in a text. Keep details for the visit or the portal.

Illustration: two screening pages

This is an invented example to show the difference, not a real practice. Page A is titled “Free diabetes test for every senior: reverse prediabetes today,” says Medicare pays for two tests a year for anyone, names a weight loss drug, and quotes one patient’s story about dropping their blood sugar. Page B is titled “Diabetes screening at your checkup,” explains who the USPSTF recommends screening, says Medicare Part B covers screening for people with certain risk factors and the front desk can check, describes what happens after a result including referral to a lifestyle program, and links the sources with their dates. Page A overstates the service and the coverage. Page B matches the sources.

Checklist before screening is promoted

The page describes who the USPSTF recommendation covers and links the statement with its date.
Medicare wording matches 42 CFR 410.18: risk factors, referral, two tests within 12 months.
Coverage wording does not promise zero cost; Medicaid details come from your own state’s current rules.
A referral list of lifestyle programs and MDPP suppliers is kept current.
No page promises to reverse prediabetes or names a treatment, and no patient story is used as an ad without review.
Event checks are covered by the office’s CLIA certificate and reviewed for inducement.
Reminders meet the conditions in 47 CFR 64.1200(a)(9)(iv) and carry no promotion or results.
A clinician, the billing lead and a health care attorney approved the pages, the forms and the messages.

How we help

We build websites, local search, Google Ads, patient lead generation and AI front desk tools for independent practices and health businesses, including primary care and internal medicine practices. For diabetes screening, that means a site that explains screening in plain words, condition pages with no ad tags, copy checked against the current USPSTF and Medicare sources before it goes live, and reminders that stay within the healthcare exemption. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it.

Who does the USPSTF recommend screening for diabetes?

The final statement dated August 24, 2021 gives a B grade to screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity, with earlier screening considered for some groups and a BMI of 23 or more considered for Asian American adults.

When should adults be screened again for diabetes?

The USPSTF says screening every 3 years may be a reasonable approach for adults with normal blood glucose levels. The clinician sets the interval for each patient.

Does Medicare cover diabetes screening?

Yes, for people with certain risk factors. Under 42 CFR 410.18, Part B covers diabetes screening tests after a referral, up to two tests within 12 months of the last screening test. Medicare.gov says the patient pays nothing if the provider accepts assignment.

What should a practice do after a prediabetes result?

The USPSTF says to offer or refer patients with prediabetes to effective preventive interventions. Keep a list of CDC-recognized lifestyle programs and, for Medicare patients who qualify under 42 CFR 410.79, enrolled MDPP suppliers.

Can we offer free blood sugar checks at a health fair?

Only with care. The test falls under CLIA rules in 42 CFR 493.3 and 493.35, and a free item offered to Medicare or Medicaid patients can raise inducement questions under 42 U.S.C. 1320a-7a. Have a health care attorney review the plan.

Can our ads say we help reverse prediabetes?

Avoid it. Describe the screening and the referral, cite the CDC figure on lifestyle programs as a research result with its source, and leave outcomes for one patient to the clinician.

Prediabetes and diabetes screening outreach: the USPSTF 2021 B grade, the Medicare benefit, referral to lifestyle programs and claims to avoid